Skip to main content

Table 3. Comparison of treatment-related factors between treatment groups I and II.

Variable Treatment group I n (%) Treatment group II n (%) P
Total (n=131) 60 71 -
Operation length (h) - - <0.001
   ≥11 (n=51) 36 15 -
   <11 (n=80) 24 56 -
Number of procedures performed - - 0.284
    >4 (n=81) 34 47 -
    ≤4 (n=50) 26 24 -
Completeness of cytoreduction - - 0.806
   Complete (CC0) (n=112) 52 60 -
   Incomplete (CC1/CC2/CC3) (n=19) 8 11 -
Red blood cell transfusion (units) - - <0.001
   ≥6 (n=70) 42 28 -
   <6 (n=61) 18 43 -
Fresh frozen plasma transfusion (units) - - 0.024
   ≥10 (n=60) 34 26 -
   <10 (n=71) 26 45 -
Cryoprecipitate transfusion (units) - - 0.020
   ≥10 (n=53) 31 22 -
   <10 (n=78) 29 49 -
Platelet transfusion (x109) - - <0.001
   ≥1 (n=29) 23 6 -
   =0 (n=102) 37 65 -
Crystalloid administration (l) - - <0.001
   ≥5 (n=55) 39 16 -
   <5 (n=76) 21 55 -
Human serum albumin 4% (l) - - 0.704
   ≥5 (n=40) 17 23 -
   <5 (n=91) 43 48 -
Colloid administration (l) - - <0.001
   ≥1 (n=39) 31 8 -
   <1(n=91) 29 62 -
FFP1st:FFP2nd ratio - - <0.001
   >1 (n=55) 16 39 -
   ≤1 (n=62) 37 25 -
RBC1st:RBC2nd ratio - - 0.016
   ≥1 (n=59) 22 37 -
   <1 (n=59) 36 23 -
Any red blood cell transfusion - - 0.009
   Yes 58 58 -
   No 2 13 -